NextCure Presented NC410 Data at the Extracellular Matrix (ECM) Pharmacology Congress in Europe on Overcoming Clinical Limitations to Immunotherapy Through Remodeling Tumor ECM
BELTSVILLE, Md., June 27, 2022 (GLOBE NEWSWIRE) — NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company…
AI Turns Vulnerability Management Into a Throughput Problem
Neutrik® Connects Made-To-Order, High-Performance AV Solutions For RCI Custom
AceDraft Announces AceDraft, a Free ATS Resume Tool to Help Gen Z Job Seekers Match Job Descriptions
uSMART Becomes the World’s First Technology Brokerage to Offer Both ‘Night and Pre-Market Trading’ in U.S. Options
Chervon Names Doug Palmer Vice President of Finance – Canada